← 返回

间充质干细胞来源细胞外囊泡当前研究概览:2009 至 2021 年文献计量学分析

英文原题:An Overview of Current Research on Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Bibliometric Analysis From 2009 to 2021.

查看英文原题

An Overview of Current Research on Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Bibliometric Analysis From 2009 to 2021.

PubMed 2022/06/24(内容时间) Front Bioeng Biotechnol Q1 · IF 5.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

间充质干细胞来源细胞外囊泡(MSC-EV)是细胞间通讯的重要介质,参与机体多种生理和病理过程。本研究旨在通过MSC-EV文献计量学分析,介绍研究现状、分析热点并预测发展趋势。

我们检索了Web of Science中2009至2021年发表的所有MSC-EV相关文献。使用R-bibliometrix、VOSviewer和CiteSpace对发表文献进行定量可视化分析,包括合作作者、共现、引用和共被引,以客观呈现该领域并开展预测。

共识别出2009至2021年发表的1595篇MSC-EV文章和综述。年发文量呈指数增长,2021年达到555篇。中国发文量最多(899篇,56.36%),被引次数也最多(24,210次)。美国在该领域合作强度最高。上海交通大学发文量最多(79篇)。按发文量和共被引次数,Stem Cell Research & Therapy排名第一。Camussi是发文量和被引次数最多的作者。该研究领域前三大主题为细胞生物学、实验医学研究和生物化学与分子生物学。关键词共现及共被引聚类分析显示,MSC-EV研究涵盖细胞来源(骨髓间充质干细胞、脂肪来源间充质干细胞)、损伤性疾病(脊髓损伤、急性肺损伤、缺血/再灌注损伤、急性肾损伤、创伤性脑损伤)、肿瘤(乳腺癌、肿瘤微环境)、生物学过程(药物递送、血管生成、炎症、增殖、分化、衰老)和分子机制(信号通路、信号转导、氧化应激、VEGF、TGF)。

近年来MSC-EV研究快速增长,现有研究主要关注其对再生障碍性疾病的治疗作用及相关机制。多学科融合是该领域的发展趋势,衰老相关主题可能成为未来MSC-EV研究重点。

展开英文摘要原文

Background: Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) are important mediators of intercellular communication and participate in numerous physiological and pathological processes in the body.

This study aims to introduce the research status, analyze the research hotspots, and predict the development trend through bibliometric analysis of MSC-EVs. Methods: We searched all relevant literature on MSC-EVs from 2009 to 2021 in the Web of Science. R-bibliometrix, VOSviewer, and CiteSpace software were used to visualize the quantitative analysis of the published literature, including co-authorship, co-occurrence, citation, and co-citation, to provide objective presentation and predictions in the field. Results: A total of 1595 articles and reviews on MSC-EVs published between 2009 and 2021 were identified. The annual publication outputs increased at an exponential rate, reaching as high as 555 publications in 2021. China contributed the most publications ( n = 899, 56. 36%) and had the most citations ( n = 24,210). The United States had the strongest intensity of cooperation in this field. Shanghai Jiao Tong University had the maximum number of publications ( n = 79). In terms of the number of publications and co-citations, the journal of Stem cell research & therapy ranked first.

Camussi G was the most productive and most cited author. The top three themes in the research area were cell biology, research experimental medicine, and biochemistry molecular biology. Keyword co-occurrence and co-citation clustering analysis revealed that studies of MSC-EVs covered cellular origin (bone marrow mesenchymal stem cell, adipose-derived mesenchymal stem cell), injurious diseases (spinal cord injury, acute lung injury, ischemia/reperfusion injury, acute kidney injury, traumatic brain injury), tumor (breast cancer, tumor microenvironment), biological processes (drug delivery system, angiogenesis, inflammation, proliferation, differentiation, senescence), and molecular mechanisms (signaling pathway, signal transduction, oxidative stress, VEGF, TGF ).

Conclusions: Studies on MSC-EVs have shown a steep growth trend in recent years. Available studies mostly focused on the therapeutic effects and underlying mechanisms of MSC-EVs in aplastic diseases. Multidisciplinary integration is a development trend in this field, and senescence-related topics might be the focus of future research on MSC-EVs.

论文信息

作者
Zhang X、Lu Y、Wu S、Zhang S、Li S、Tan J
单位
Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.China
期刊
Frontiers in bioengineering and biotechnology2022
原文标识
PubMed 35814000 · DOI 10.3389/fbioe.2022.910812